Related Experiment Video
Updated: Jun 18, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools
1Clinical Trials Co-ordinating Centre, Faculty of Health and Human Sciences, University of Hertfordshire, College Lane, Hatfield, Herts, UK. kirbym@globalnet.co.uk
Objectives:
The aim of this study was to evaluate the Joint British Societies' (JBS 2) Factfile, cardiovascular risk assessment paper charts and electronic risk calculator posted to health professionals in general practice.
Design:
Phase one: surveys on use of the JBS 2 charts and calculator; views on improving use and acceptability. Phase two: six focus groups and two semi-structured interviews on use of the JBS 2 charts and calculator; views on expression of risk, communication of risk and risk management.
Participants:
Phase one: general practitioners (GPs) and practice nurses. Phase two: GPs, practice nurses and nurse practitioners recruited via the survey; eligible patients invited by GPs.
Setting:
Primary care.
Results:
A high response rate (81.3%, 825/1015) was obtained to a national on-line survey of GPs using Pearl Medical Blackberries((R)). The JBS 2 charts were used by around 1 in 5 GPs and the electronic risk calculator by around 1 in 6. Patients and health professionals found the concept of risk difficult, preferred relative to absolute risk and liked the JBS 2 electronic risk thermometer and its ability to illustrate how changes in risk factors affect risk levels. Communication of risk in visual terms was a key to understanding the concept. The most important factor was risk management; how to motivate and support patients to maintain healthy lifestyles and concordance with medication was as important as communication of risk. Health professionals need training in both aspects.
Conclusions:
To maximise the use of cardiovascular risk assessment tools, multiple approaches are needed; it is not sufficient to distribute them in the post. Communicating and managing cardiovascular risk is difficult; to be effective more time is needed than is available in a routine GP appointment. Practice nurses may be well suited for this role. Costs of training and continuing support need to be built into the overall costs of the national programme for cardiovascular screening now known as NHS Health Checks.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:26Coronary Artery Disease IV: Preventive Measures
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...